Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Cutaneous ultrasound in the diagnosis and assessment of inflammatory activity in tinea capitis.
Australas J Ultrasound Med
November 2024
Department of Dermatology Hospital Universitario Puerta de Hierro Majadahonda Calle Joaquín Rodrigo, 1, Majadahonda 28222 Madrid Spain.
Introduction: Although the diagnosis of tinea capitis is mainly microbiological, the risk of evolution towards cicatricial alopecia in the most severe cases requires empirical treatment based on physical examination and complementary examinations.
Methods: Two patients were evaluated by physical examination, cutaneous ultrasound and microbiological examination.
Results: Ultrasound showed follicular widening and increased vascularization in Doppler mode.
[Quelles indications pour la corticothérapie dans la BPCO ?].
Rev Prat
May 2024
Service de pneumologie, Inserm UMRS 1250, CHU de Reims, Reims, France.
WHAT ARE THE INDICATIONS FOR CORTICOSTEROID THERAPY IN COPD? In stable state chronic obstructive pulmonary disease (COPD), inhaled corticosteroids (ICS) should be used in case of frequent exacerbation only, associated with long-term bronchodilators including long-acting beta-agonist (LABA) and long-acting muscarinic antagonist (LAMA). When frequent exacerbations persist despite dual inhaled therapy (LABA + CSI or LABA+LAMA), triple inhaled therapy (LAMA+LABA+CSI) is indicated. In COPD exacerbation, the level of evidence for systemic corticosteroids is very low, justifying not to systematically prescribe systemic corticosteroids and when used to restrict this use to short-term (5 days) and low doses.
View Article and Find Full Text PDFTherapeutic Plasma Exchange in Catastrophic Antiphospholipid Syndrome (CAPS): A Rare Case Report and Literature Review.
In Vivo
June 2023
Faculty of Medicine, "Lucian Blaga" University of Sibiu, Sibiu, Romania.
Background/aim: Catastrophic antiphospholipid syndrome (CAPS) may be the first manifestation ("de novo") of antiphospholipid syndrome (APS) or a complication in the clinical course of patients known to have this syndrome. Approximately 40% of patients had an associated autoimmune disease, mainly, systemic lupus erythematosus (SLE). The trigger can be one of the following: infections, surgical interventions, neoplasms, pregnancy, discontinuation of anticoagulant treatment, and others.
View Article and Find Full Text PDFA new therapeutic protocol for the treatment of keloid scars: a retrospective study.
J Wound Care
March 2021
Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75010 Paris, France.
Objective: There are few means to treat large keloid scars, as exeresis-even if partial-impedes direct closure without tension in the absence of a flap or a skin graft. This study evaluates the efficacy, indications for use and limitations of a new therapeutic protocol, combining an extralesional keloid excision left to heal by secondary intention with a paraffin dressing and glucocorticoid ointment, followed by monthly intrascar injections of corticosteroids upon full re-epithelialisation.
Method: A retrospective study of patients treated for keloid scars by using the new therapeutic protocol.
Background: Stomatitis associated with targeted oncological therapy, typically everolimus related one, belongs among the major complications affecting the quality of life of a patient and intensity of his/her oncological treatment. Corticosteroids, especially for topical application, represent a major therapeutic and possibly prophylactic intervention.
Purpose: Basic summary of clinical characteristics, incidence and overview of possibilities of influencing the incidence of stomatitis related to targeted oncological therapy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!